Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioredoxin-Interacting Protein (TXNIP)
- Target
- TXNIP
- Molecular classification
- α-arrestin, Transcription factor
01
Overview
Thioredoxin-interacting protein (TXNIP) is a member of the α-arrestin family that acts as an endogenous inhibitor of thioredoxin (TRX). By binding to TRX, TXNIP modulates cellular redox reactions, glucose homeostasis, inflammation, and cell death. It plays a complex role in various diseases, acting as a tumor suppressor in some cancers while contributing to the pathogenesis of metabolic syndromes and neurodegenerative disorders. Its role in regulating oxidative stress makes it a potential therapeutic target, but also presents safety concerns due to its complex interactions and downstream effects.
- Other names
- TBP2Vitamin D3–upregulated protein 1
02
Mechanism of action
Inhibition of thioredoxin (TRX) via disulfide bond formation, leading to increased intracellular ROS levels and oxidative stress.
03
Biological functions
Redox regulationGlucose/energy metabolismInflammationApoptosisTranscriptional repression
04
Disease associations
Diabetes mellitus/metabolic syndromeCancer/tumor suppressionNeurodegenerationCardiovascular diseasesInflammatory illnessesBone metabolism-related diseases
05
Safety considerations
Dysregulation or overexpression associated with metabolic syndromes.Potential for altered apoptotic signaling in various diseases.
Beyond the preview
Go deeper on Thioredoxin-Interacting Protein (TXNIP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thioredoxin-Interacting Protein (TXNIP).